Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.750
+0.150 (4.17%)
At close: Aug 29, 2025, 4:00 PM
3.690
-0.060 (-1.60%)
After-hours: Aug 29, 2025, 4:10 PM EDT
Molecular Partners AG Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Molecular Partners AG.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Molecular Partners AG.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $6.6 → $4.5 | Hold | Maintains | $6.6 → $4.5 | +20.00% | Dec 5, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $30 → $8 | Buy → Hold | Downgrades | $30 → $8 | +113.33% | Aug 29, 2022 |
| Credit Suisse | Credit Suisse | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | May 25, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $29 | Buy | Maintains | $42 → $29 | +673.33% | Apr 27, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $35 → $42 | Buy | Maintains | $35 → $42 | +1,020.00% | Jan 14, 2022 |
Financial Forecast
Revenue This Year
1.02M
from 4.97M
Decreased by -79.48%
Revenue Next Year
11.22M
from 1.02M
Increased by 1,000.00%
EPS This Year
-1.56
from -1.59
EPS Next Year
-1.49
from -1.56
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.1M | 23.1M | |||
| Avg | 1.0M | 11.2M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -57.7% | 2,164.7% | |||
| Avg | -79.5% | 1,000.0% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.52 | -0.98 | |||
| Avg | -1.56 | -1.49 | |||
| Low | -1.57 | -1.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.